PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...

The treatment of a subdural hematoma received a major boost with three new randomized controlled trials all showing large and significant benefits of a new embolization process done as an endovascular ...

A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...

A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...

BARCELONA, Spain — A new randomized trial of embolization of the middle meningeal artery (EMMA) following surgery for chronic subdural hematoma showed striking results, with a major drop in hematoma ...

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid™ liquid embolic agent. Squid is approved for the embolization of the middle ...

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...

MMA embolization procedures to treat SDH increased significantly, from 4,014 in 2019 to 20,836 in 2023, representing a 51% compound annual growth rate. By 2030, it is expected to surpass the annual ...

BOSTON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Balt, Inc., a global technology leader in neurovascular devices, today announced the publication of The Squid Trial for the Embolization of the Middle ...

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid(TM) liquid embolic agent. Squid is approved for the embolization of the ...

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery.- ...